Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
February-2021 Volume 21 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2021 Volume 21 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Identification of thrombomodulin as a dynamic monitoring biomarker for deep venous thrombosis evolution

  • Authors:
    • Xi Cheng
    • Baolan Sun
    • Shiyi Liu
    • Dandan Li
    • Xiaoqing Yang
    • Yuquan Zhang
  • View Affiliations / Copyright

    Affiliations: Medical College, Nantong University, Nantong, Jiangsu 226001, P.R. China, Department of Gynecology and Obstetrics, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China
    Copyright: © Cheng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 142
    |
    Published online on: December 14, 2020
       https://doi.org/10.3892/etm.2020.9574
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

It has been demonstrated that thrombomodulin (TM) serves an important role in the formation of deep venous thrombosis (DVT) and is regarded to be a marker that can be used to measure vascular endothelial cell damage. However, how TM levels change during DVT evolution has not yet been well understood. The current study aimed to investigate the dynamic changes of TM during the evolution of DVT and explore the possible mechanisms behind these. A total of 48 patients newly diagnosed with DVT and 23 matched healthy controls were enrolled in the present study, and their plasma TM levels were examined and compared. In addition, a DVT model was established using Sprague‑Dawley rats via the ‘stenosis’ method. The thrombi size, histopathologic changes and expression of TM and NF‑κB in plasma and venous endothelium were measured at 9 different time points (1, 4, 6, 12 and 24 h, and at 3, 7, 14 and 21 days). Finally, the effect of inhibiting the activation of NF‑κB on TM was investigated using pyrrolidine dithiocarbamate (PDTC), which is a potent inhibitor of the NF‑κB pathway. The results of the current study indicated that the mean level of plasma TM in patients with DVT was significantly increased compared with healthy controls. In addition, thrombi size (clot length and weight), TM and NF‑κB expression in the animal model plasma exhibited three distinct periods (1‑12, 24 h‑day 7 and 14‑21) of markedly different results between periods. Immunofluorescence results confirmed the co‑localization of TM and NF‑κB in endothelial cells. In addition, it was indicated that the expression of TM in the endothelium of DVT models was upregulated compared with the control, while NF‑κB was significantly downregulated. Following the administration of PDTC, the level of NF‑κB and TM in the plasma were decreased significantly dose‑dependently. The results of the current study suggested that TM was involved in the evolution of DVT and may be used as a dynamic biomarker to measure disease activity. Furthermore, the expression of TM during the evolution of DVT was indicated to be associated with the NF‑κB signaling pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Di Nisio M, van Es N and Büller HR: Deep vein thrombosis and pulmonary embolism. Lancet. 388:3060–3073. 2016.PubMed/NCBI View Article : Google Scholar

2 

Thomas M, Hollingsworth A and Mofidi R: Endovascular management of acute lower limb deep vein thrombosis: A systematic review and meta-analysis. Ann Vasc Surg. 58:363–370. 2019.PubMed/NCBI View Article : Google Scholar

3 

Galanaud JP, Monreal M and Kahn SR: Epidemiology of the post-thrombotic syndrome. Thromb Res. 164:100–109. 2018.PubMed/NCBI View Article : Google Scholar

4 

Shin M, Hino H, Tamura M, Ishizuka B, Tanaka M, Suzuki N and Tateda T: Thrombomodulin improves maternal and fetal conditions in an experimental pre-eclampsia rat model. J Obstet Gynaecol Res. 40:1226–1234. 2014.PubMed/NCBI View Article : Google Scholar

5 

Anastasiou G, Gialeraki A, Merkouri E, Politou M and Travlou A: Thrombomodulin as a regulator of the anticoagulant pathway: Implication in the development of thrombosis. Blood Coagul Fibrinolysis. 23:1–10. 2012.PubMed/NCBI View Article : Google Scholar

6 

Fu Y, Liu Y, Chen S, Jin Y and Jiang H: The combination of caprini risk assessment scale and thrombotic biomarkers to evaluate the risk of venous thromboembolism in critically ill patients. Medicine (Baltimore). 97(e13232)2018.PubMed/NCBI View Article : Google Scholar

7 

Salvagno GL, Pavan C and Lippi G: Rare thrombophilic conditions. Ann Transl Med. 6(342)2018.PubMed/NCBI View Article : Google Scholar

8 

Hoesel B and Schmid JA: The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 12(86)2013.PubMed/NCBI View Article : Google Scholar

9 

Zhang Q, Lenardo MJ and Baltimore D: 30 Years of NF-κB: A blossoming of relevance to human pathobiology. Cell. 168:37–57. 2017.PubMed/NCBI View Article : Google Scholar

10 

Shirai Y, Uwagawa T, Shiba H, Shimada Y, Horiuchi T, Saito N, Furukawa K, Ohashi T and Yanaga K: Recombinant thrombomodulin suppresses tumor growth of pancreatic cancer by blocking thrombin-induced PAR1 and NF-κB activation. Surgery. 161:1675–1682. 2017.PubMed/NCBI View Article : Google Scholar

11 

Ma J and Bai J: Protective effects of heparin on endothelial cells in sepsis. Int J Clin Exp Med. 8:5547–5552. 2015.PubMed/NCBI

12 

Wu CT, Chang YH, Lin P, Chen WC and Chen MF: Thrombomodulin expression regulates tumorigenesis in bladder cancer. BMC Cancer. 14(375)2014.PubMed/NCBI View Article : Google Scholar

13 

Menschikowski M, Hagelgans A, Tiebel O, Vogel M, Eisenhofer G and Siegert G: Regulation of thrombomodulin expression in prostate cancer cells. Cancer Lett. 322:177–184. 2012.PubMed/NCBI View Article : Google Scholar

14 

Song D, Ye X, Xu H and Liu SF: Activation of endothelial intrinsic NF-{kappa}B pathway impairs protein C anticoagulation mechanism and promotes coagulation in endotoxemic mice. Blood. 114:2521–2529. 2009.PubMed/NCBI View Article : Google Scholar

15 

Liang W, Wei F, Yang C, Xie F, Shuai XX, Wang M and Yu M: GDF-15 is associated with thrombus burden in patients with deep venous thrombosis. Thromb Res. 187:148–153. 2020.PubMed/NCBI View Article : Google Scholar

16 

Yao X, Chen W, Liu J, Liu H, Zhan JY, Guan S, Lu Z, Tang P, Li P and Lin B: Deep vein thrombosis is modulated by inflammation regulated via sirtuin 1/NF-κB signalling pathway in a rat model. Thromb Haemost. 119:421–430. 2019.PubMed/NCBI View Article : Google Scholar

17 

Qin JD, Cao ZH, Li XF, Kang XL, Xue Y, Li YL, Zhang D, Liu XY and Xue YZ: Effect of ammonium pyrrolidine dithiocarbamate (PDTC) on NF-κB activation and CYP2E1 content of rats with immunological liver injury. Pharm Biol. 52:1460–1466. 2014.PubMed/NCBI View Article : Google Scholar

18 

Yin J, Wu M, Duan J, Liu G, Cui Z, Zheng J, Chen S, Ren W, Deng J, Tan X, et al: Pyrrolidine dithiocarbamate inhibits NF-KappaB activation and upregulates the expression of Gpx1, Gpx4, occludin, and ZO-1 in DSS-induced colitis. Appl Biochem Biotechnol. 177:1716–1728. 2015.PubMed/NCBI View Article : Google Scholar

19 

Zhang Z, Hu L, Chen W, Zhou C, Gui G and Lin B: Danhong huayu koufuye prevents deep vein thrombosis through anti-inflammation in rats. J Surg Res. 201:340–347. 2016.PubMed/NCBI View Article : Google Scholar

20 

Diaz JA, Obi AT, Myers DD Jr, Wrobleski SK, Henke PK, Mackman N and Wakefield TW: Critical review of mouse models of venous thrombosis. Arterioscler Thromb Vasc Biol. 32:556–562. 2012.PubMed/NCBI View Article : Google Scholar

21 

Vukojevic J, Siroglavic M, Kasnik K, Kralj T, Stancic D, Kokot A, Kolaric D, Drmic D, Sever AZ, Barisic I, et al: Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157. Vascul Pharmacol. 106:54–66. 2018.PubMed/NCBI View Article : Google Scholar

22 

Sharma A, Fish BL, Moulder JE, Medhora M, Baker JE, Mader M and Cohen EP: Safety and blood sample volume and quality of a refined retro-orbital bleeding technique in rats using a lateral approach. Lab Anim (NY). 43:63–66. 2014.PubMed/NCBI View Article : Google Scholar

23 

Goicoechea M, Cía F, San José C, Asensio A, Emparanza JI, Gil AG, López de Cerain A, Aldazabal P, Azpitarte M, Otaegui D and López de Munain A: Minimizing creatine kinase variability in rats for neuromuscular research purposes. Lab Anim. 42:19–25. 2008.PubMed/NCBI View Article : Google Scholar

24 

Bagot CN and Arya R: Virchow and his triad: A question of attribution. Br J Haematol. 143:180–190. 2008.PubMed/NCBI View Article : Google Scholar

25 

Iba T and Levy JH: Inflammation and thrombosis: Roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis. J Thromb Haemost. 16:231–241. 2018.PubMed/NCBI View Article : Google Scholar

26 

Vazquez-Garza E, Jerjes-Sanchez C, Navarrete A, Joya-Harrison J and Rodriguez D: Venous thromboembolism: Thrombosis, inflammation, and immunothrombosis for clinicians. J Thromb Thrombolysis. 44:377–385. 2017.PubMed/NCBI View Article : Google Scholar

27 

Ochi A, Adachi T, Inokuchi K, Ogawa K, Nakamura Y, Chiba Y, Kawasaki S, Onishi Y, Onuma Y, Munetsugu Y, et al: Effects of aging on the coagulation fibrinolytic system in outpatients of the cardiovascular department. Circ J. 80:2133–2140. 2016.PubMed/NCBI View Article : Google Scholar

28 

Bombeli T, Jutzi M, De Conno E, Seifert B and Fehr J: In patients with deep-vein thrombosis elevated levels of factor VIII correlate only with von Willebrand factor but not other endothelial cell-derived coagulation and fibrinolysis proteins. Blood Coagul Fibrinolysis. 13:577–581. 2002.PubMed/NCBI View Article : Google Scholar

29 

Sane M, Granér M, Laukkanen JA, Harjola VP and Mustonen P: Plasma levels of haemostatic factors in patients with pulmonary embolism on admission and seven months later. Int J Lab Hem. 40:66–71. 2018.PubMed/NCBI View Article : Google Scholar

30 

Kalayci A, Gibson CM, Chi G, Yee MK, Korjian S, Datta S, Nafee T, Gurin M, Haroian N, Qamar I, et al: Asymptomatic deep vein thrombosis is associated with an increased risk of death: Insights from the APEX trial. Thromb Haemost. 118:2046–2052. 2018.PubMed/NCBI View Article : Google Scholar

31 

Kearon C, Comp P, Douketis J, Royds R, Yamada K and Gent M: Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost. 3:962–968. 2005.PubMed/NCBI View Article : Google Scholar

32 

Ayala-Ramírez P, Buitrago T, Poveda A, Rodríguez JL, Olaya-C M and García-Robles R: Increased tissue factor and thrombomodulin expression and histopathological changes in placentas of pregnancies with preeclampsia. J Neonatal Perinatal Med. 9:31–39. 2016.PubMed/NCBI View Article : Google Scholar

33 

Li YD, Ye BQ, Zheng SX, Wang JT, Wang JG, Chen M, Liu JG, Pei XH, Wang LJ, Lin ZX, et al: NF-kappaB transcription factor p50 critically regulates tissue factor in deep vein thrombosis. J Biol Chem. 284:4473–4483. 2009.PubMed/NCBI View Article : Google Scholar

34 

Li G, Zhou R, Zhao X, Liu R and Ye C: Correlation between the expression of IL-18 and deep venous thrombosis. Int J Mol Med. 42(2972)2018.PubMed/NCBI View Article : Google Scholar

35 

Deng HF, Wang S, Li L, Zhou Q, Guo WB, Wang XL, Liu MD, Liu K and Xiao XZ: Puerarin prevents vascular endothelial injury through suppression of NF-ΚB activation in LPS-challenged human umbilical vein endothelial cells. Biomed Pharmacother. 104:261–267. 2018.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Cheng X, Sun B, Liu S, Li D, Yang X and Zhang Y: Identification of thrombomodulin as a dynamic monitoring biomarker for deep venous thrombosis evolution. Exp Ther Med 21: 142, 2021.
APA
Cheng, X., Sun, B., Liu, S., Li, D., Yang, X., & Zhang, Y. (2021). Identification of thrombomodulin as a dynamic monitoring biomarker for deep venous thrombosis evolution. Experimental and Therapeutic Medicine, 21, 142. https://doi.org/10.3892/etm.2020.9574
MLA
Cheng, X., Sun, B., Liu, S., Li, D., Yang, X., Zhang, Y."Identification of thrombomodulin as a dynamic monitoring biomarker for deep venous thrombosis evolution". Experimental and Therapeutic Medicine 21.2 (2021): 142.
Chicago
Cheng, X., Sun, B., Liu, S., Li, D., Yang, X., Zhang, Y."Identification of thrombomodulin as a dynamic monitoring biomarker for deep venous thrombosis evolution". Experimental and Therapeutic Medicine 21, no. 2 (2021): 142. https://doi.org/10.3892/etm.2020.9574
Copy and paste a formatted citation
x
Spandidos Publications style
Cheng X, Sun B, Liu S, Li D, Yang X and Zhang Y: Identification of thrombomodulin as a dynamic monitoring biomarker for deep venous thrombosis evolution. Exp Ther Med 21: 142, 2021.
APA
Cheng, X., Sun, B., Liu, S., Li, D., Yang, X., & Zhang, Y. (2021). Identification of thrombomodulin as a dynamic monitoring biomarker for deep venous thrombosis evolution. Experimental and Therapeutic Medicine, 21, 142. https://doi.org/10.3892/etm.2020.9574
MLA
Cheng, X., Sun, B., Liu, S., Li, D., Yang, X., Zhang, Y."Identification of thrombomodulin as a dynamic monitoring biomarker for deep venous thrombosis evolution". Experimental and Therapeutic Medicine 21.2 (2021): 142.
Chicago
Cheng, X., Sun, B., Liu, S., Li, D., Yang, X., Zhang, Y."Identification of thrombomodulin as a dynamic monitoring biomarker for deep venous thrombosis evolution". Experimental and Therapeutic Medicine 21, no. 2 (2021): 142. https://doi.org/10.3892/etm.2020.9574
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team